--- title: "Research Analysts Issue Forecasts for Gevo FY2029 Earnings" type: "News" locale: "en" url: "https://longbridge.com/en/news/278334912.md" description: "Analysts at HC Wainwright have raised their FY2029 earnings estimates for Gevo, Inc. (NASDAQ:GEVO) from $0.95 to $1.09 per share. The company recently reported Q4 earnings of ($0.02) per share, exceeding expectations, with revenues of $45.35 million. Gevo's stock has seen a positive sentiment due to management's expansion plans and significant revenue growth. Currently, the stock has a consensus rating of \"Hold\" with an average target price of $6.42. Institutional investors hold 35.17% of the shares, indicating growing interest in the company." datetime: "2026-03-09T05:57:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/278334912.md) - [en](https://longbridge.com/en/news/278334912.md) - [zh-HK](https://longbridge.com/zh-HK/news/278334912.md) --- # Research Analysts Issue Forecasts for Gevo FY2029 Earnings - 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments Gevo, Inc. (NASDAQ:GEVO - Free Report) - Analysts at HC Wainwright boosted their FY2029 earnings estimates for Gevo in a research note issued to investors on Friday, March 6th. HC Wainwright analyst A. Dayal now forecasts that the energy company will post earnings of $1.09 per share for the year, up from their previous estimate of $0.95. The consensus estimate for Gevo's current full-year earnings is ($0.42) per share. Gevo (NASDAQ:GEVO - Get Free Report) last announced its quarterly earnings data on Thursday, March 5th. The energy company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.01. The company had revenue of $45.35 million for the quarter, compared to analysts' expectations of $43.52 million. Gevo had a negative return on equity of 7.20% and a negative net margin of 21.07%. - October's 4 Best Penny Stocks: High-Risk, High-Reward Picks GEVO has been the topic of a number of other research reports. Northland Securities reissued an "outperform" rating and set a $3.00 price target on shares of Gevo in a research report on Wednesday, December 31st. Weiss Ratings restated a "sell (d-)" rating on shares of Gevo in a report on Thursday, January 22nd. Finally, Wall Street Zen lowered shares of Gevo from a "hold" rating to a "sell" rating in a research note on Saturday. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $6.42. **Get Our Latest Analysis on GEVO** ## Gevo Trading Up 13.2% - Gevo's Cash Flow, Small Cap Buying Back Shares Shares of NASDAQ GEVO opened at $2.14 on Monday. The company has a quick ratio of 1.58, a current ratio of 1.82 and a debt-to-equity ratio of 0.35. The business has a fifty day simple moving average of $1.94 and a two-hundred day simple moving average of $2.04. The firm has a market cap of $518.54 million, a PE ratio of -16.46 and a beta of 1.51. Gevo has a twelve month low of $0.92 and a twelve month high of $2.95. ## Institutional Investors Weigh In On Gevo Several institutional investors have recently bought and sold shares of GEVO. Key Client Fiduciary Advisors LLC purchased a new position in Gevo in the fourth quarter worth $25,000. Berger Financial Group Inc purchased a new stake in shares of Gevo during the 4th quarter valued at $26,000. BNP Paribas Financial Markets lifted its holdings in shares of Gevo by 138.1% during the 2nd quarter. BNP Paribas Financial Markets now owns 20,927 shares of the energy company's stock valued at $28,000 after purchasing an additional 12,136 shares during the last quarter. Franklin Resources Inc. purchased a new stake in shares of Gevo during the 4th quarter valued at $28,000. Finally, Legal & General Group Plc acquired a new stake in shares of Gevo in the 2nd quarter worth $28,000. 35.17% of the stock is currently owned by institutional investors and hedge funds. ## Key Gevo News Here are the key news stories impacting Gevo this week: - Positive Sentiment: Management set a target of $40M adjusted EBITDA in 2026 and announced expansion of its North Dakota platform to increase carbon capture and ethanol output — a concrete profitability milestone and capacity push that supports upside to future cash flow and valuation. Gevo targets $40M adjusted EBITDA in 2026 as North Dakota platform expands carbon and ethanol operations - Positive Sentiment: Q4 results topped expectations: revenue of ~$45.4M beat consensus and EPS loss of ($0.02) was slightly better than estimates, signaling improving unit economics versus a year ago. That beat helped lift sentiment. Gevo Q4 earnings & transcript (MarketBeat) - Positive Sentiment: Management highlighted dramatic revenue growth (reported commentary cited ~849% increase year-over-year) and ongoing SAF/ethanol expansion plans, reinforcing the growth narrative that investors reward. Gevo Inc (GEVO) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion ... - Neutral Sentiment: The company posted its full Q4 and FY2025 release and slide deck with operational and cash-flow updates; investors can review the slides for detailed project timing and capex cadence. Gevo Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Neutral Sentiment: Earnings-call transcripts and analyst previews are available for detail on timing and commercial contracts; the call contains forward-looking statements that will shape near-term expectations. Gevo Q4 2025 Earnings Call Transcript - Negative Sentiment: Despite beats, Gevo remains unprofitable with negative net margin and negative ROE; management must convert revenue growth into sustained positive margins to justify the rally. Gevo, Inc. (GEVO) Reports Q4 Loss, Tops Revenue Estimates - Negative Sentiment: Analysts and the market are focused on clarity around the near-term earnings path; uncertainty on timing of SAF/ethanol ramp and capital needs means execution risk remains elevated. What Gevo (GEVO)'s Latest Earnings and Guidance Reveal About Its Near‑Term Earnings Path ## About Gevo (Get Free Report) Gevo, Inc NASDAQ: GEVO is a renewable chemicals and biofuels company that develops and produces low-carbon alternatives to petroleum-based products. The company's core technology platform converts fermentable sugars into isobutanol, which can be further processed into sustainable aviation fuel (SAF), renewable gasoline, diesel, and jet fuel. Gevo's integrated biorefinery model combines fermentation, recovery, and downstream processing to deliver scalable, drop-in replacements for conventional fossil-derived hydrocarbons. Gevo's primary products include isobutanol, a four-carbon alcohol used as a building block for various fuels and chemicals, and hydrocarbon fuels that meet ASTM specifications for aviation and road transport. ## Featured Stories - Five stocks we like better than Gevo - The gold chart Wall Street is terrified of… - America’s 1776 happening again - What a Former CIA Agent Knows About the Coming Collapse - Elon Musk already made me a “wealthy man” - Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in Gevo Right Now? Before you consider Gevo, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gevo wasn't on the list. While Gevo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [GEVX.US](https://longbridge.com/en/quote/GEVX.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [GEVO.US](https://longbridge.com/en/quote/GEVO.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) ## Related News & Research - [Gevo withdraws from DoE loan program, will seek alternative funding for ATJ-30 project](https://longbridge.com/en/news/282905074.md) - [Gevo Withdraws Financing Application With Department of Energy](https://longbridge.com/en/news/282904482.md) - [Gossamer Bio Receives Nasdaq Minimum Bid Price Deficiency Notice](https://longbridge.com/en/news/282247265.md) - [Arcutis Biotherapeutics Targets ZORYVE Expansion, Raises 2026 Outlook and Turns Cash-Flow Positive](https://longbridge.com/en/news/282775123.md) - [FDA Rejection Sparks Questions On Replimune Drug Approval Path](https://longbridge.com/en/news/282577359.md)